|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of iRadimed (NASDAQ: IRMD) through any online brokerage.
The latest price target for iRadimed (NASDAQ: IRMD) was reported by Roth Capital on August 2, 2021. The analyst firm set a price target for 36.00 expecting IRMD to fall to within 12 months (a possible -25.77% downside). 1 analyst firms have reported ratings in the last year.
The stock price for iRadimed (NASDAQ: IRMD) is $48.5 last updated Today at 3:52:04 PM.
There are no upcoming dividends for iRadimed.
iRadimed’s $Q4 earnings are confirmed for after-market on February 3, 2022.
There is no upcoming split for iRadimed.
iRadimed is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.